Acetone

Acetone

SCHEMBL2311348

CC(C)=O.ClCCCl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetone SCHEMBL27430340 0.96 LMNA (0.50)
Acetic Acid SCHEMBL495776 0.87
Acetone SCHEMBL6859028 0.86 LMNA (0.60)
Acetone SCHEMBL1831044 0.86 LMNA (0.60)
Acetone SCHEMBL292856 0.86 LMNA (0.60)
Acetone SCHEMBL6859386 0.86 LMNA (0.60)
Acetone SCHEMBL9324675 0.86 LMNA (0.60)
Acetone SCHEMBL6859109 0.86 LMNA (0.60)
Acetone SCHEMBL1244296 0.86 LMNA (0.60)
Acetone SCHEMBL9217023 0.86 LMNA (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106178972-B A kind of preparation method of high temperature resistant PPS gas separation membrane 天津津纶新材料科技有限公司 2019-09-27 CN claimed
CN-106178972-A A kind of preparation method of high temperature resistant PPS gas separation membrane 太原市晋华恒远科技有限公司 2016-12-07 CN claimed
CN-110520411-A The manufacturing method of pyridine compounds SUMITOMO CHEMICAL CO 2019-11-29 CN disclosed
US-10328068-B2 Oral pharmaceutical dosage forms DURECT CORPORATION (US) 2019-06-25 US disclosed
CN-108690027-A A kind of 2- difluoro methylenes substituted pyrimidines and &amp;#91;1,2-a&amp;#93;Benzimidazole compound and its preparation and application 广州大学 2018-10-23 CN disclosed
US-20180214435-A1 ORAL PHARMACEUTICAL DOSAGE FORMS ORIENT PHARMA CO., LTD. (TW) 2018-08-02 US disclosed
US-9884056-B2 Oral pharmaceutical dosage forms DURECT CORPORATION (US) 2018-02-06 US disclosed
US-20170252330-A1 Oral Pharmaceutical Dosage Forms ORIENT PHARMA CO., LTD. (TW) 2017-09-07 US disclosed
US-9616055-B2 Oral pharmaceutical dosage forms DURECT CORPORATION (US) 2017-04-11 US disclosed
US-20160058746-A1 Oral Pharmaceutical Dosage Forms ORIENT PHARMA CO., LTD. (TW) 2016-03-03 US disclosed
EP-1507867-B1 PROCESS FOR FERMENTATION OF PHYTOSTEROLS TO ANDROSTADIENEDIONE ORGANON NV (NL) 2011-08-03 EP disclosed
US-4443619-A MULTISTEP PREPARATION OF MONOPOTASSIUM DIHYDROGEN THREO-EPOXYACONITATE FROM TRANSACONITIC ACID HOFFMANN-LA ROCHE INC. (US) 1984-04-17 US disclosed
US-4439183-A Parenteral agent dispensing equipment ALZA CORPORATION (US) 1984-03-27 US disclosed
US-4434153-A Drug delivery system comprising a reservoir containing a plurality of tiny pills ALZA CORPORATION (US) 1984-02-28 US disclosed
US-4365070-A B-LACTONE INTERMEDIATES THEREOF, ANORECTIC AGENTS FOR TREATMENT OBESITY HOFFMANN-LA ROCHE INC. (US) 1982-12-21 US disclosed
US-4354039-A Chlorocitric acids HOFFMANN-LA ROCHE INC. (US) 1982-10-12 US disclosed
US-4353919-A Analgesic and antipyretic pharmaceutical compositions containing a benzothiazol-2(3H)-one DR. KARL THOMAE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1982-10-12 US disclosed
US-4352758-A FROM TRANS-ACONITIC ACID HOFFMANN-LA ROCHE INC. (US) 1982-10-05 US disclosed
US-4340754-A Process for making chlorocitric acid HOFFMANN-LA ROCHE INC. (US) 1982-07-20 US disclosed
US-4312885-A ANORECTIC AGENTS FOR TREATMENT OF OBESITY HOFFMANN-LA ROCHE INC. (US) 1982-01-26 US disclosed